Granisetron is used for: Nausea and vomiting; Chemotherapy-induced nausea and vomiting; Post-operative nausea and vomiting.
Recorded in the NepalDoc medicine catalog for Granisetron.
Granisetron hydrochloride injection is a serotonin-3 (5-HT 3 ) receptor antagonist indicated for: The prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin., The prevention and treatment of postoperative nausea and vomiting in adults.
From the U.S. FDA-approved label for Granisetron. Full label: DailyMed.
Granisetron hydrochloride injection is a serotonin-3 (5-HT 3 ) receptor antagonist indicated for: The prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin., The prevention and treatment of postoperative nausea and vomiting in adults. In patients where nausea and/or vomiting must be avoided during the postoperative period, granisetron hydrochloride injection is recommended even where the incidence of postoperative nausea and/or vomiting is low.
From the U.S. FDA-approved label for Granisetron. Full label: DailyMed.
Prevention of chemotherapy-induced nausea and vomiting: Recommended dosage is 10 mcg/kg intravenously within 30 minutes before initiation of chemotherapy, Pediatric patients (2 to 16 years): Recommended dosage is 10 mcg/kg Prevention of postoperative nausea and vomiting: Recommended dosage is 1 mg, undiluted, administered intravenously over 30 seconds, before anesthetic induction or immediately before reversal of anesthesia.
Directions from the U.S. FDA-approved label for Granisetron — your doctor or pharmacist may advise differently.
Granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components., Hypersensitivity to granisetron or to any of its components.
Excerpt from the U.S. FDA-approved label for Granisetron. Talk to a pharmacist or doctor before use.
Granisetron hydrochloride does not stimulate gastric or intestinal peristalsis and should not be used instead of nasogastric suction., QT prolongation has been reported with granisetron hydrochloride. Use with caution in patients with pre-existing arrhythmias or cardiac conduction disorders., Hypersensitivity reactions, such as anaphylaxis, shortness of breath, hypotension, and urticaria, may occur in patients with known hypersensitivity to other selective 5-HT 3 receptor antagonists., Serotonin syndrome has been reported with granisetron products, alone but particularly with concomitant use of serotonergic drugs.
Warnings and precautions excerpt from the U.S. FDA-approved label for Granisetron — not a complete list. Talk to a pharmacist or doctor before use.
QT prolongation has been reported with granisetron hydrochloride. Most common adverse reactions: Chemotherapy-induced nausea and vomiting (≥3%): Headache, and constipation, Postoperative nausea and vomiting (≥2%): Pain, headache, fever, abdominal pain and hepatic enzymes increased To report SUSPECTED ADVERSE REACTIONS, contact Mylan Pharmaceuticals Inc.at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or…
Excerpt from the U.S. FDA-approved label for Granisetron — not a complete list. Talk to a pharmacist or doctor about side effects.
9 brands · 5 makers in the NepalDoc catalog — see the full Granisetron guide →
Store at 20° to 25°C (68° to 77°F); Protect from light.
Storage information from the U.S. FDA-approved label for Granisetron.
What is Grandem?
Grandem 1mg Tablet is a Granisetron medicine made by Aristo Pharmaceuticals Ltd. It comes as 1mg Tablet.
What is Grandem used for?
Granisetron is used for Nausea and vomiting, Chemotherapy-induced nausea and vomiting, Post-operative nausea and vomiting.
What is the generic name of Grandem?
The generic name of Grandem is Granisetron.
Which brands of Granisetron are available in Nepal?
9 brands of Granisetron are listed in the NepalDoc catalog, from 5 makers — including Biogram 3mg Injection, G ron 1mg Tablet, Grandem 1mg Injection, Grandem 10ml Syrup, Grandem MD 1mg Tablet, Graniset 1mg Tablet.
What are the side effects of Granisetron?
QT prolongation has been reported with granisetron hydrochloride.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
